Kajubi,1 in his letter to the editor, which was published in the February 14, 2000, issue of the ARCHIVES, makes a good case for the use of aspirin in type 2 diabetes mellitus, "in the absence of contraindications." Many patients with chronic diabetes have diabetic retinopathy and neovascularization and are prone to fundal bleeding. When should aspirin be contraindicated in a patient with diabetic retinopathy?